NCT04310007 2026-04-13Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung CancerNational Cancer Institute (NCI)Phase 2 Active not recruiting117 enrolled
NCT06635824 2026-04-08Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06)GenmabPhase 3 Active not recruiting191 enrolled
NCT06632327 2026-04-07Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung CancerAlliance for Clinical Trials in OncologyPhase 3 Recruiting1,100 enrolled
NCT06012435 2026-03-18A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung CancerSeagen Inc.Phase 3 Active not recruiting703 enrolled